Drug Research
Samsung Bioepis and C-Bridge Capital to Develop and Commercialize Next-Generation Biosimilars in China
Samsung Bioepis Co., Ltd. announced its expansion in mainland China through a licensing agreement with C-Bridge Capital. The agreement covers multiple...
News
CRF Bracket Moves Clinical Trials Forward at the 10th Annual SCOPE Summit
Running a seamless clinical trial means improving not only data quality but also operational logistics and most importantly the patient experience. ...
Press Releases
Lonza Launches New Reliable, Robust and Customizable Pooled Donor Suspension Hepatocytes
Lonza announces the launch of DonorPlex Hepatocytes, a new line of high-quality cryopreserved pooled donor suspension hepatocytes, which are the first of their kind...
Press Releases
MedPharm announce expansion of partnership with Palvella Therapeutics in developing a new treatment for the debilitating rare disease
MedPharm Ltd have announced the expansion of their partnership with Palvella Therapeutics, Inc., a Philadelphia-based biopharmaceutical company focused on developing and commercialising therapies for...
Press Releases
Silgan Dispensingโs Iridya Addresses Unmet Patient Needs in Ophthalmic Drug Delivery Market
Silgan Dispensing, a global leader in the design, development and manufacturing of highly engineered pumps and sprayers in the pharmaceutical, home and beauty markets,...
Research Insight
Lonza and AllCells Join Forces for Global Commercialization of Hematopoietic Primary Cells
Lonza and AllCells have entered into a private label partnership for the manufacture and global commercialization of an extensive range of hematopoietic primary cells....
Packaging & Labelling
Aptar Pharma QuickStart Injectables, a Drug Development Solution Available Online, Wins Industry Innovation Award at Pharmapack 2019
Aptar Pharma, a leading provider of innovative drug delivery systems, has announced that their recently-launched QuickStart for Injectables has won Best Innovation in Packaging...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
















